RESEARCH USE ONLY: All products are for laboratory research purposes only. Not for human or animal consumption.
By using this site, you confirm you are 21+ and acknowledge these products are not FDA approved.
JR
Jason R.
✓ Verified Buyer
24 days ago
Arrived cold packed and intact. Easy to match the batch info.
Mechanism of Action
Tesamorelin is a stabilized GHRH(1-44) analogue with an N-terminal modification. FDA-approved as Egrifta for HIV-associated lipodystrophy, it specifically promotes visceral adipose tissue lipolysis through restored GH signaling while preserving subcutaneous fat.
Metabolic effects of a growth hormone-releasing factor in patients with HIV
PMID: 18057338
Falutz J, Allas S, et al.
— New England Journal of Medicine (2007)
Tesamorelin reduced visceral adipose tissue by 15.2% vs 5.0% increase with placebo
Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation
PMID: 25038357
Stanley TL, Feldpausch MN, et al.
— JAMA (2014)
Tesamorelin reduced visceral adipose tissue by 9.9% and produced significant liver fat reductions
Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial
PMID: 31611038
Stanley TL, Fourman LT, et al.
— Lancet HIV (2019)
37% relative hepatic fat reduction with tesamorelin and attenuated fibrosis progression
Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation
PMID: 20101189
Falutz J, Potvin D, et al.
— Journal of Acquired Immune Deficiency Syndromes (2010)
Confirmatory Phase III showing ~18% visceral fat reduction
Storage
Store lyophilized peptide at -20°C for long-term stability. Reconstituted solution should be stored at 2-8°C and used within 30 days. Avoid repeated freeze-thaw cycles.
Reconstitution
Reconstitute with bacteriostatic water (0.9% benzyl alcohol). Add solvent slowly down the side of the vial. Do not shake; gently swirl until dissolved.
Purity & Testing
Purity verified at ≥99.2% by HPLC. Each lot includes Certificate of Analysis with mass spectrometry confirmation and endotoxin testing.
Research Use Only
This product is intended for laboratory research purposes only. Not for human or animal consumption. Not FDA-approved for therapeutic use. Handle according to institutional biosafety protocols.
Frequently Asked Questions about Tesamorelin
What is Tesamorelin?
Tesamorelin (GHRH Analog) is a research-grade peptide supplied at 5mg/vial with ≥99.20% HPLC-verified purity. Synthetic GHRH analog for GH axis and lipodystrophy research.
What purity is your Tesamorelin?
Our Tesamorelin is verified at ≥99.20% purity by High-Performance Liquid Chromatography (HPLC). Each lot includes a Certificate of Analysis with mass spectrometry confirmation and endotoxin testing results.
How should I store Tesamorelin?
Store lyophilized Tesamorelin at -20°C for optimal long-term stability. After reconstitution with bacteriostatic water, store at 2-8°C and use within 30 days. Avoid repeated freeze-thaw cycles to maintain peptide integrity.
Do you offer bulk discounts on Tesamorelin?
Yes. We offer tiered pricing: 3-vial packs include a 7% discount and 5-vial packs include a 14% discount. All multi-vial options are available on this product page above.
Is Tesamorelin third-party tested?
Yes. Every batch of Tesamorelin is independently tested by third-party laboratories using HPLC and mass spectrometry. Certificate of Analysis available upon request. All products are manufactured under ISO-compliant conditions.
Related Endocrinology & Somatotropic Signaling Peptides